Copertina

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Alan Priester, Sakina Mohammed Mota, Kyla P. Grunden, Joshua Shubert, Shannon Richardson, Anthony Sisk, Ely R. Felker, James Sayre, Leonard S. Marks, Shyam Natarajan, Wayne G. Brisbane
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	BJUI Compass
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
di: Ailene E. Corona, et al.
Pubblicazione: (2026)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
di: Muhammad Imran, et al.
Pubblicazione: (2026)

Exploring patient and clinician opinions, perspectives and acceptance of the use of artificial intelligence in the histological diagnosis of prostate cancer
di: Lisa Browning, et al.
Pubblicazione: (2025)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
di: Mathew Thakur, et al.
Pubblicazione: (2024)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
di: Maxwell Louis Sandberg, et al.
Pubblicazione: (2026)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
di: Eric Margolis, et al.
Pubblicazione: (2025)

Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach
di: Harry Collin, et al.
Pubblicazione: (2024)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
di: Esther H. J. Hamoen, et al.
Pubblicazione: (2025)

Using an artificial intelligence‐based device to investigate pain outcomes in robotic prostatectomy at low pressure pneumoperitoneum: The RALP clinical trial
di: Nikhil Vasdev, et al.
Pubblicazione: (2026)

The carbon footprint of transperineal prostate biopsy
di: Daniel A. Carson, et al.
Pubblicazione: (2025)

Emerging tools for the early detection of prostate cancer
di: Muhammad Haider, et al.
Pubblicazione: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
di: Sophia M. Abusamra, et al.
Pubblicazione: (2025)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
di: Abel Tesfai, et al.
Pubblicazione: (2024)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
di: Ansh Bhatia, et al.
Pubblicazione: (2024)

Bibliometric analysis of focal therapy in prostate cancer research
di: Mohammed Shahait, et al.
Pubblicazione: (2024)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
di: Ryan Sutherland, et al.
Pubblicazione: (2024)

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
di: André B. Silva, et al.
Pubblicazione: (2026)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
di: Eric V. Li, et al.
Pubblicazione: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
di: Nikhil Mayor, et al.
Pubblicazione: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
di: Nadia Rokan, et al.
Pubblicazione: (2025)

Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
di: Emilien Seizilles de Mazancourt, et al.
Pubblicazione: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
di: Ruth Pidsley, et al.
Pubblicazione: (2024)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
di: Mohamad Baker Berjaoui, et al.
Pubblicazione: (2024)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
di: Geneva Pantoja, et al.
Pubblicazione: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
di: Sofia Mesquita, et al.
Pubblicazione: (2025)

Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
di: Lu Yu Kuo, et al.
Pubblicazione: (2025)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
di: Pierre Allainguillaume, et al.
Pubblicazione: (2026)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
di: Jeremy Cheng, et al.
Pubblicazione: (2025)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
di: Samantha Shekar, et al.
Pubblicazione: (2025)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
di: Jonathon Dawson, et al.
Pubblicazione: (2024)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
di: Marcus Sondermann, et al.
Pubblicazione: (2025)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
di: Arjun Pon Avudaiappan, et al.
Pubblicazione: (2024)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
di: Muhammad Haider, et al.
Pubblicazione: (2025)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
di: Sandra Irenaeus, et al.
Pubblicazione: (2025)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
di: Austin Drysch, et al.
Pubblicazione: (2025)

Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta‐analysis
di: Sean Lim, et al.
Pubblicazione: (2024)

Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer
di: Jennifer Dunsmore, et al.
Pubblicazione: (2024)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
di: Herbert Lepor, et al.
Pubblicazione: (2025)

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
di: Ali H. Zahalka, et al.
Pubblicazione: (2024)

First validation of the Prostatype® P‐score in an Asian cohort: Improving risk stratification for prostate cancer
di: See‐Tong Pang, et al.
Pubblicazione: (2025)